- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Pleasanton Today
By the People, for the People
Veeva Systems Stock Rating Upgraded by Zacks Research
Analysts see strong growth potential for the cloud software company serving the life sciences industry.
Apr. 17, 2026 at 12:08pm
Got story updates? Submit your updates here. ›
Veeva Systems' robust cloud software platform powers the complex data and regulatory infrastructure of the life sciences industry.Pleasanton TodayInvestment research firm Zacks Research has upgraded its rating on Veeva Systems (NYSE: VEEV) from 'hold' to 'strong buy', citing the company's growth prospects in the life sciences software market. Veeva provides cloud-based content management, clinical trial, and commercial operations software to pharmaceutical, biotech, and medical device companies.
Why it matters
Veeva Systems is a leading provider of mission-critical software for the highly regulated life sciences industry. The company's strong market position and continued product innovation have made it a favorite among analysts, despite recent stock price volatility. This upgrade signals Zacks' confidence in Veeva's ability to maintain its growth trajectory.
The details
In a research note, Zacks cited Veeva's robust product portfolio and expanding customer base as key factors behind the upgrade. The firm also noted the company's focus on developing new applications and expanding internationally. Veeva's Vault platform, which provides content management and clinical trial solutions, has been a major driver of the company's success.
- Zacks Research issued the upgrade on Wednesday, April 17, 2026.
The players
Veeva Systems
A cloud software company that develops industry-specific applications and data solutions for the global life sciences sector, founded in 2007 and headquartered in Pleasanton, California.
Zacks Research
An investment research firm that provides stock analysis and ratings to investors.
What’s next
Investors will be closely watching Veeva's upcoming earnings reports and guidance to see if the company can deliver on Zacks' strong buy rating. The firm's ability to continue expanding its product suite and customer base will be key factors in determining the stock's future performance.
The takeaway
Veeva Systems' upgrade to a 'strong buy' rating from Zacks Research underscores the company's dominant position in the life sciences software market and its potential for continued growth. As the industry's reliance on cloud-based solutions increases, Veeva appears well-positioned to capitalize on this trend.
